235 filings
Page 2 of 12
10-Q
2022 Q3
INLB
Item 9 Labs Corp.
Quarterly report
15 Aug 22
5:19pm
8-K
INLB
Item 9 Labs Corp.
3 Jun 22
Departure of Directors or Certain Officers
4:13pm
8-K
INLB
Item 9 Labs Corp.
24 May 22
Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada’s Largest Cannabis Retail Franchisors
5:17pm
10-Q
2022 Q2
INLB
Item 9 Labs Corp.
Quarterly report
16 May 22
4:15pm
8-K
INLB
Item 9 Labs Corp.
16 May 22
Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million
12:00am
253G2
INLB
Item 9 Labs Corp.
4 May 22
Offering circular supplement
9:07am
8-K
INLB
Item 9 Labs Corp.
17 Mar 22
Entry into a Material Definitive Agreement
5:47pm
8-K
INLB
Item 9 Labs Corp.
4 Mar 22
Item 9 Labs Corp. Closes Acquisition of Adams County, Colorado Dispensary
1:55pm
8-K
INLB
Item 9 Labs Corp.
2 Mar 22
Item 9 Labs Corp. Strengthens Board of Directors with Appointment of Massage Heights Founder
10:13am
QUALIF
INLB
Item 9 Labs Corp.
28 Feb 22
Notice of qualification
12:15am
CORRESP
INLB
Item 9 Labs Corp.
23 Feb 22
Correspondence with SEC
12:00am
1-A/A
INLB
Item 9 Labs Corp.
22 Feb 22
Offering $67.2M in Units, consisting of one share of Common Stock and one-half of one Warrant. Only whole warrants can be exercised to purchase one share of Common Stock from date of issuance until the second anniversary of the date of issuance.
8:51pm
8-K
INLB
Item 9 Labs Corp.
15 Feb 22
Item 9 Labs Corp. Announces First Quarter FY 2022 Financial Results with Revenue Growth of 104% to $6.2 Million
9:33am
10-Q
2022 Q1
INLB
Item 9 Labs Corp.
Quarterly report
14 Feb 22
12:00am
UPLOAD
INLB
Item 9 Labs Corp.
8 Feb 22
Letter from SEC
12:00am
1-A
INLB
Item 9 Labs Corp.
2 Feb 22
Offering $42M in Units, consisting of one share of Common Stock and one Warrant to purchase one share of Common Stock from date of issuance until the second anniversary of the date of issuance.
2:47pm
8-K
INLB
Item 9 Labs Corp.
2 Feb 22
Departure of Directors or Certain Officers
12:00am
8-K
INLB
Item 9 Labs Corp.
18 Jan 22
Item 9 Labs Corp. Reports Record FY 2021 Annual Financial Results with Revenue Growth of 170% to $21.9 Million Revenue
9:30am
10-K
2021 FY
INLB
Item 9 Labs Corp.
Annual report
13 Jan 22
5:05pm
8-K
INLB
Item 9 Labs Corp.
11 Jan 22
Regulation FD Disclosure
11:36am